학술논문

New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies
Document Type
article
Source
Journal of Investigative Dermatology. 141(10)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Psoriasis
Clinical Research
Autoimmune Disease
Rare Diseases
Arthritis
2.1 Biological and endogenous factors
Aetiology
Inflammatory and immune system
Skin
Arthritis
Psoriatic
Cardiovascular Diseases
Comorbidity
Humans
Molecular Targeted Therapy
Oncology and Carcinogenesis
Dermatology & Venereal Diseases
Clinical sciences
Language
Abstract
Although psoriasis and psoriatic arthritis (PsA) have been classically considered to be diseases of the skin and joints, respectively, emerging evidence suggests that a combination of innate and environmental factors creates widespread immune dysfunction, affecting multiple organ systems. A greater understanding of the pathogenesis of psoriasis and the systemic effects of psoriatic inflammation has allowed for the development of new, more effective treatments. The second portion of this two-part review series examines the comorbidities associated with psoriasis and PsA as well as the most recent advances in targeted systemic therapies for these conditions.